Animal studies are now underway to find out how tumor TLR4 expression levels may impact the anti-tumor efficacy of the anti-PAUF treatment, and to explore the synergistic anti-tumor efficacy of inhibition on both TLR4/MyD88 dependent PAUF and B7-H3. The gene discussed is MYD88; the disease is neoplasm.